Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Multiple Sclerosis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

China Medical University Hospital, Taichung, Non-US, Taiwan
Contact: Study coordinator (Sammi Hsu) · cthsu@ever-supreme.com.tw
Contact: Principal Investigator (Yuh C Guo, MD)

Study leads

Woei C Shyu
Study Chair
Ever Supreme Bio Technology Co., Ltd.

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Impact of Anodal tDCS and Virtual Reality on Cognitive Dysfunction in Patients With Multiple Sclerosis

Cognitive Impairment · Multiple Sclerosis

Abroad (travel likely)Recruiting

Genova, Italy · Genova, Italy

A Study to Evaluate Pharmacokinetics (PK) and Safety of Subcutaneous (SC) Ublituximab Administered at Various Injection Sites and Relative Bioavailability Via Autoinjector (AI) Versus Syringe Subcutaneously in Participants With Multiple Sclerosis (MS)

Multiple Sclerosis

Abroad (travel likely)RecruitingPHASE2

Bihać, Bosnia and Herzegovina · Sarajevo, Bosnia and Herzegovina

Mechanisms of Cannabidiol in Persons With MS: the Role of Sleep and Pain Phenotype

Multiple Sclerosis · Sleep · Pain

Abroad (travel likely)RecruitingPHASE2

Ann Arbor, United States

Hyperpolarized Carbon Metabolic Imaging in Multiple Sclerosis

Multiple Sclerosis · RRMS · Relapsing Remitting MS

Abroad (travel likely)RecruitingPHASE2

San Francisco, United States